Dimensional Fund Advisors’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Dimensional Fund Advisors’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12,946	Closed	-$1.39M	–	3545
2023 Q1	$1.39M	Buy	+12,946	New	+$1.49M	﹤0.01%	2827
2022 Q2	–	Sell	-18,904	Closed	-$714K	–	3551
2022 Q1	$714K	Buy	+18,904	New	+$747K	﹤0.01%	3071

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Dimensional Fund Advisors's RXDX Position: Q2 2023 in Review

Dimensional Fund Advisors sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 12,946 shares — an estimated $1.39M sold.

Dimensional Fund Advisors first reported a position in RXDX in Q1 2022 and held it in 2 quarters. The position peaked at $1.39M in Q1 2023. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

Dimensional Fund Advisors reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Dimensional Fund Advisors sold 12,946 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $1.39M.
Dimensional Fund Advisors first reported a position in Prometheus Biosciences, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
Dimensional Fund Advisors's Prometheus Biosciences, Inc. Common Stock position peaked at $1.39M in Q1 2023.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Dimensional Fund Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.